Drug Type Fusion protein |
Synonyms SFR-9X-012-2 |
Target |
Mechanism VEGFR agonists(Vascular endothelial growth factor receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Corneal Injuries | Discovery | CN | - |